ATE527282T1 - Tumor assoziierte antigene - Google Patents

Tumor assoziierte antigene

Info

Publication number
ATE527282T1
ATE527282T1 AT03722712T AT03722712T ATE527282T1 AT E527282 T1 ATE527282 T1 AT E527282T1 AT 03722712 T AT03722712 T AT 03722712T AT 03722712 T AT03722712 T AT 03722712T AT E527282 T1 ATE527282 T1 AT E527282T1
Authority
AT
Austria
Prior art keywords
associated antigens
tumor associated
tumours
disclosed
utilised
Prior art date
Application number
AT03722712T
Other languages
English (en)
Inventor
Alison Banham
Karen Pulford
Amanda Anderson
Barbara Guinn
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Innovation filed Critical Isis Innovation
Application granted granted Critical
Publication of ATE527282T1 publication Critical patent/ATE527282T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03722712T 2002-03-27 2003-03-27 Tumor assoziierte antigene ATE527282T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0207251.0A GB0207251D0 (en) 2002-03-27 2002-03-27 Lymphoma-associated antigens
PCT/GB2003/001378 WO2003082916A2 (en) 2002-03-27 2003-03-27 Tumour associated antigens

Publications (1)

Publication Number Publication Date
ATE527282T1 true ATE527282T1 (de) 2011-10-15

Family

ID=9933833

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03722712T ATE527282T1 (de) 2002-03-27 2003-03-27 Tumor assoziierte antigene

Country Status (5)

Country Link
EP (1) EP1490398B1 (de)
AT (1) ATE527282T1 (de)
AU (1) AU2003229876A1 (de)
GB (1) GB0207251D0 (de)
WO (1) WO2003082916A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005282489A1 (en) * 2004-09-08 2006-03-16 Cornell Research Foundation, Inc. Cancer-testis antigens
GB0818080D0 (en) 2008-10-02 2008-11-05 Isis Innovation Immunogenic peptides
JP2022537581A (ja) * 2019-06-21 2022-08-26 クラリス コーポレーション Ｐｐｍ１阻害剤およびその使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922566A (en) * 1997-05-13 1999-07-13 Incyte Pharmaceuticals, Inc. Tumor-associated antigen
WO2001062917A1 (en) * 2000-02-22 2001-08-30 Ludwig Institute For Cancer Research Isolated genomic sequences which encode the ny-eso-1 cancer testis tumor antigen and uses thereof
WO2003011902A1 (en) * 2001-07-27 2003-02-13 Kenton S.R.L. Identification of specific tumour antigens by selection of cdna libraries with sera

Also Published As

Publication number Publication date
AU2003229876A8 (en) 2003-10-13
EP1490398A2 (de) 2004-12-29
EP1490398B1 (de) 2011-10-05
WO2003082916A3 (en) 2004-03-18
WO2003082916A2 (en) 2003-10-09
AU2003229876A1 (en) 2003-10-13
GB0207251D0 (en) 2002-05-08

Similar Documents

Publication Publication Date Title
TNSN05300A1 (en) Treatment with anti-vegf antibodies
MY146533A (en) Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
WO2004113571A3 (en) Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis
EP1503788A4 (de) Behandlung des alpha-galactosidase a mangels
MX358618B (es) Usos de inhibidores de dpp iv.
CY1116052T1 (el) Θεραπευτικα και διαγνωστικα αντι-ηsρ70 αντισωματα
DK1294437T3 (da) Anordning til afskærmning over for magnetiske og elektriske felter
CY1111565T1 (el) Θεραπεια συνδυασμου του zd6474 με 5-fu και/ή cpt-11
AR031250A1 (es) Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon
CY1106259T1 (el) Συνδυασμενη θepαπεια που πepιλαμβανει zd6474 κι ενα ταξανιο
NO20032027L (no) Effektive antitumorbehandlinger
ATE442861T1 (de) Gegen antikörper gerichtete photodynamische therapie
ATE406897T1 (de) Kombination von et-743 mit 5-fluorouracil pro- drugs zur behandlung von krebs
IL327342A (en) Combination of anti-claudin 18.2/anti-4-1BB antibodies and a second therapeutic agent in the treatment of cancer
AU2020327022A8 (en) Method of treating cancer
AU2003229876A8 (en) Tumour associated antigens
IL159770A0 (en) Calcium salts with cytotoxic activity
TW200724158A (en) Combination therapy in the treatment of cancer
EP1351967A4 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
ATE291620T1 (de) Mammakarzinom-assoziiertes gen
NO20044709L (no) Kombinasjonsterapi mot tumorer omfattende substituerte akryloyldistamycinderivater og rontgenbehandling
ATE537838T1 (de) Kombinationstherapie mit kloretazin(tm)
MXPA05002477A (es) Asialo-interferones y el tratamiento de cancer de higado.
AU2003253050A8 (en) Diagnosis and therapy of breast tumours resistant to antiestrogen treatment
MXPA02001238A (es) Uso de la hidralazina y procanaimida en el tratamiento de cancer como reactivadores de la expresion de genes supresores de tumores.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties